Activation of IGF1R/p110β/AKT/mTOR confers resistance to α-specific PI3K inhibition

por Leroy, Cedric, Ramos, Pedro, Cornille, Karen, Bonenfant, Debora, Fritsch, Christine, Voshol, Hans, Bentires-Alj, Mohamed
Publicado 2016

Inhibition of DDR1‐BCR signalling by nilotinib as a new therapeutic strategy for metastatic colorectal cancer

por Jeitany, Maya, Leroy, Cédric, Tosti, Priscillia, Lafitte, Marie, Le Guet, Jordy, Simon, Valérie, Bonenfant, Debora, Robert, Bruno, Grillet, Fanny, Mollevi, Caroline, El Messaoudi, Safia, Otandault, Amaëlle, Canterel‐Thouennon, Lucile, Busson, Muriel, Thierry, Alain R, Martineau, Pierre, Pannequin, Julie, Roche, Serge, Sirvent, Audrey
Publicado 2018

N-acetylcysteine overcomes NF1 loss-driven resistance to PI3Kα inhibition in breast cancer

por Auf der Maur, Priska, Trefny, Marcel P., Baumann, Zora, Vulin, Milica, Correia, Ana Luisa, Diepenbruck, Maren, Kramer, Nicolas, Volkmann, Katrin, Preca, Bogdan-Tiberius, Ramos, Pedro, Leroy, Cedric, Eichlisberger, Tobias, Buczak, Katarzyna, Zilli, Federica, Okamoto, Ryoko, Rad, Roland, Jensen, Michael Rugaard, Fritsch, Christine, Zippelius, Alfred, Stadler, Michael B., Bentires-Alj, Mohamed
Publicado 2023